Delivery Order SPE2DB20D1110-SPE2DB24FK51A

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,232.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of VALTOCO 10 MG nasal sprays. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The delivery order has a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,553.70, for the provision of VALTOCO 20 MG Nasal Sprays. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies,...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,254.36 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VALTOCO 10 MG nasal sprays. This Firm Fixed Price contract has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $2,209.20 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the supply of VALTOCO 10 MG NASAL SPRAYS. This order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,063.34 Firm Fixed Price Delivery Order is for the supply of VALTOCO 10 MG NASAL SPRAYS. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,833.76 firm fixed-price contract is for the supply of VALTOCO 10 MG NASAL SPRAYS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,847.54 firm fixed-price delivery order is for the supply of VALTOCO 20 MG Nasal Sprays. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of medical commodities from Amerisourcebergen to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 10 MG NASAL SPRAYS. The contract has a ceiling value of $1,355.52 and a completion date of January 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of VALTOCO 20 MG nasal sprays. The contract has a potential value of $1,670.44 and a completion date of February 29, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK51A
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,333.22 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of VALTOCO 5 MG NASAL SPRAYS. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which allows for the efficient procurement of a comprehensive range of pharmaceutical and medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and the ultimate completion date is September 5, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide critical medical supplies and prescription drugs to various federal agencies and healthcare programs.

Generated 12/4/24, 9:57 AM